CN102335312A - Chinese medicine for treating vitiligo - Google Patents
Chinese medicine for treating vitiligo Download PDFInfo
- Publication number
- CN102335312A CN102335312A CN2011103268117A CN201110326811A CN102335312A CN 102335312 A CN102335312 A CN 102335312A CN 2011103268117 A CN2011103268117 A CN 2011103268117A CN 201110326811 A CN201110326811 A CN 201110326811A CN 102335312 A CN102335312 A CN 102335312A
- Authority
- CN
- China
- Prior art keywords
- medicine
- chinese medicine
- radix
- vitiligo
- white macula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicine for treating vitiligo. The Chinese medicine consists of kusnezoff monkshood root, ligusticum wallichii, Angelica sinensis, fructus psoraleae, angelica dahurica, dragon's blood, safflower, common monkshood mother root, periostracum cicada, astragalus, tuckahoe, and liquorice in a weight part ratio of (50-80):(50-750):(150-200):(400-600):(150-200):(100-130):(100-140):(50-80):(50-75):(200-300):(150-200):(150-300). The Chinese medicine is unique and reasonable in compatibility, and has the advantages of short treatment course, quick response, low treatment cost, and high cure rate and vitiligo does not relapse easily after being cured. Specifically, a patient under 30 years, who is in the initial stage of vitiligo or has a few lesion sites can be radically treated after taking the Chinese medicine for one month.
Description
Technical field
The present invention relates to a kind of Chinese medicine, especially relate to the leukodermic Chinese medicine of a kind of treatment.
Background technology
The leukodermic skin that shows as has either large or small white macula to occur, and is prone to diffusion and recurrence.Vitiligo not only influences patient's appearance, the patient learnt normally, and employment, marriage, family, social activities etc. cause and seriously influence; And vitiligo in some cases may threat to life, and like skin carcinoma, feeling oneself inferior etc. causes that suicide, vitiligo can bring out multiple disease; Like pernicious anemia, alopecia areata, psoriasis, malignant tumor; Bronchial asthma, diseases such as rheumatoid arthritis and cataract, and disease such as concurrent hyperthyroidism.Must draw attention, cure disease as early as possible.All can not thoroughly effect a radical cure but be used to treat leukodermic medicine at present, very easily recurrence.
Summary of the invention
The technical problem that the present invention will solve provide a kind of cure rate high, be difficult for recurrence, the leukodermic Chinese medicine of treatment that medical expense is low.
In order to solve the problem that prior art exists, the technical scheme that the present invention adopts is:
The leukodermic Chinese medicine of a kind of treatment is made up of following component: Radix Aconiti Kusnezoffii: Rhizoma Chuanxiong: Radix Angelicae Sinensis: Fructus Psoraleae: the Radix Angelicae Dahuricae: Sanguis Draxonis: Flos Carthami: Radix Aconiti: Periostracum Cicadae: the Radix Astragali: Poria: Radix Glycyrrhizae=50-80:500-750:150-200:400-600:150-200:100-130:100-140:50-80:50-75:200-300:150-200:150-300 according to the following number of weight ratio.
The leukodermic Chinese medicine of described a kind of treatment is made up of following component: Radix Aconiti Kusnezoffii: Rhizoma Chuanxiong: Radix Angelicae Sinensis: Fructus Psoraleae: the Radix Angelicae Dahuricae: Sanguis Draxonis: Flos Carthami: Radix Aconiti: Periostracum Cicadae: the Radix Astragali: Poria: Radix Glycyrrhizae=60:620:180:500:180:120:125:60:65:260:170:220 according to the following number of weight ratio.
Advantage and effect that the present invention had are:
Compatibility of drugs of the present invention is rationally unique, the advantage that have short treating period, instant effect, medical expense is low, cure rate is high, the healing back is difficult for recurrence.No matter the state of an illness is in active stage or at stable phase; No matter vitiligo, the patient at any age of any kind of, use medicine of the present invention all can stain occur about two months at any position of skin in the affected part; Up to the approaching normal colour of skin; Especially for the age below 30 years old, be in their early stage or the less person of site of pathological change according to take 3 of the capsules that medicine of the present invention processes at every turn, once a day, halfhour method is taken medicine and can thoroughly be cured in 1 month after supper.Medicine of the present invention is clinic trial 7 years, minimum patient age 10 years old, and maximum patient age 70 years old is listed below some concrete cases at present:
1. yellow river: the man, 23 years old, period of expansion the completeness vitiligo, the back of the hand, face and shank have obvious white macula, area is bigger.Take the capsule for treating that medicine of the present invention is processed, each 3, once a day, take medicine half an hour after supper, and white macula is under control rapidly after taking medicine 20 days, and then SM is about 60 days, and white macula has thoroughly disappeared.
2. week is female: the man, and 51 years old, the state of an illness arrived stable phase, and abdominal part and waist and buttocks have large-area white macula; Take the capsule for treating that medicine of the present invention is processed, each 3, once a day, take medicine half an hour after supper; After 30 days, the white macula position has stain to occur, after continue to take medicine of the present invention, stain is more and more; Near the normal colour of skin, after taking medicine 3 months, vitiligo is thoroughly cured.
3. Liu Yi ice: the woman, 14 years old, femoribus internus had the imperfection white macula of an Ovum Anas domestica size and with diffusion tendency; Take the capsule for treating that medicine of the present invention is processed, each 3, once a day; Take medicine half an hour after supper; The white macula position is controlled and become pink after 15 days, takes medicine 30 days, thoroughly cures.Followed up a case by regular visits to after the drug withdrawal 3 months, vitiligo is not seen recurrence.
4. opening roc flies: the man, 29 years old, left side face and eye had obvious white macula, did not cure in ill 6 years.Take the capsule for treating that medicine of the present invention is processed, each 3, once a day, take medicine half an hour after supper, and the white macula area dwindles behind the one and a half months, and after taking medicine three months, white macula disappears without a trace.
5. Wang Yu is precious: the woman, 70 years old, cervical region, chest large tracts of land completeness white macula belonged to general hair style vitiligo.Take the capsule for treating that medicine of the present invention is processed, each 3, once a day, take medicine half an hour after supper, and after 3 months, the state of an illness is cured basically.
6. Chen Jun peak: the man, 26 years old, being dispersed in property vitiligo showed a plurality of positions such as hands, foot, cervical region.Once did the vitiligo laser therapy, took a turn for the better to some extent but recurrence is again very soon taken the capsule for treating that medicine of the present invention is processed, each 3; Once a day, take medicine half an hour after supper, a wheat harvesting period; The state of an illness takes a turn for the better gradually, after continue again to take a wheat harvesting period, the state of an illness is thoroughly cured.Followed up a case by regular visits to after the drug withdrawal 6 months, vitiligo is not seen recurrence.
7. Liu Qiang: the man, 18 years old, the segmental vitiligo, left side arm and shank have obvious white macula, take the capsule for treating that medicine of the present invention is processed, and each 3, once a day, take medicine half an hour after supper, 1 month, thoroughly cures.
8. Tong is joyful: the woman, and 21 years old, acra property vitiligo, facial, brothers refer to that toe all has the small size white macula and with development trend; Took medicine 15 days, the state of an illness is controlled, takes the capsule for treating that medicine of the present invention is processed, each 3; Once a day, take medicine half an hour after supper, and one month, the state of an illness transferred upward swing to by period of expansion; Pigment zone occurs, infiltrate to white macula central authorities gradually, took medicine 2 months, white macula is thoroughly cured.
9. Lee is patriotic: the man, and 22 years old, the completeness vitiligo, buttocks has big white macula of monobasic coin and diffusion gradually; Mr. Li cures in time, takes the capsule for treating that medicine of the present invention is processed, and each 3, once a day; Take medicine half an hour after supper, and 15 days, white macula edge pigment was deepened; The area of white macula reduces gradually, takes medicine one month, and vitiligo is thoroughly cured.Followed up a case by regular visits to after the drug withdrawal 3 months, always not recurrence.
10. golden sunlight cover: the man, 17 years old, the limitation vitiligo showed on the arm of right side, takes the capsule for treating that medicine of the present invention is processed, and each 3, once a day, take medicine half an hour after supper, and 30 days, white macula disappeared, and followed up a case by regular visits to after the drug withdrawal 3 months, always not recurrence.
11. open grain husk: the woman, 55 years old, chest lamellar white macula, the part point-like, obscure boundary, diffusion gradually belongs to general property of homeliness type vitiligo.White macula has partly reached more than 50% of skin.Take the capsule for treating that medicine of the present invention is processed, each 3, once a day, take medicine half an hour after supper, and behind the one and a half months, the white macula position has stain to occur gradually, took medicine 2 months, and the stain very dense, after taking medicine 3 months, white macula is cured basically.
12. paddy will is magnificent: the man, 19 years old, waist, shank had the point-like white macula, took the capsule for treating that medicine of the present invention is processed, and each 3, once a day, take medicine half an hour after supper, and 15 days, white macula disappeared, and after 1 month, vitiligo is thoroughly cured.
The specific embodiment
Embodiment 1:
The leukodermic Chinese medicine of a kind of treatment is processed by the following weight Chinese medicinal raw materials: Radix Aconiti Kusnezoffii 60g, Rhizoma Chuanxiong 620g, Radix Angelicae Sinensis 180g, Fructus Psoraleae 500g, Radix Angelicae Dahuricae 180g, Sanguis Draxonis 120g, Flos Carthami 125g, Radix Aconiti 60g, Periostracum Cicadae 65g, Radix Astragali 260g, Poria 170g, Radix Glycyrrhizae 220g.
It is subsequent use that above-mentioned each single medicinal material is ground into 100 purpose powder, gets the powder of above-mentioned raw materials medicine according to the above ratio, and fully mix homogeneously is processed the oral Chinese patent medicine of powder type.
Embodiment 2:
The leukodermic Chinese medicine of a kind of treatment is made up of following component: Radix Aconiti Kusnezoffii 50g, Rhizoma Chuanxiong 750g, Radix Angelicae Sinensis 200g, Fructus Psoraleae 600g, Radix Angelicae Dahuricae 200g, Sanguis Draxonis 130g, Flos Carthami 140g, Radix Aconiti 80g, Periostracum Cicadae 75g, Radix Astragali 300g, Poria 200g, Radix Glycyrrhizae 300g according to the following number of weight ratio.
It is subsequent use that above-mentioned each single medicinal material is ground into 100 purpose powder, gets the powder of above-mentioned raw materials medicine according to the above ratio, fully processes the oral Chinese patent medicine of capsule formulation behind the mix homogeneously, every capsules dress 0.2g Chinese medicine.
Embodiment 3:
The leukodermic Chinese medicine of a kind of treatment is made up of following component: Radix Aconiti Kusnezoffii 80g, Rhizoma Chuanxiong 500g, Radix Angelicae Sinensis 150g, Fructus Psoraleae 400g, Radix Angelicae Dahuricae 150g, Sanguis Draxonis 100g, Flos Carthami 100g, Radix Aconiti 50g, Periostracum Cicadae 50g, Radix Astragali 200g, Poria 150g, Radix Glycyrrhizae 150g according to the following number of weight ratio.
It is subsequent use that above-mentioned each single medicinal material is ground into 100 purpose powder, gets the powder of above-mentioned raw materials medicine according to the above ratio, and fully mix homogeneously is processed the oral Chinese patent medicine of capsule formulation, every capsules dress 0.2g Chinese medicine.
Embodiment 4:
The leukodermic Chinese medicine of a kind of treatment is made up of following component: Radix Aconiti Kusnezoffii 75g, Rhizoma Chuanxiong 550g, Radix Angelicae Sinensis 165g, Fructus Psoraleae 440g, Radix Angelicae Dahuricae 190g, Sanguis Draxonis 125g, Flos Carthami 137g, Radix Aconiti 75g, Periostracum Cicadae 70g, Radix Astragali 280g, Poria 190g, Radix Glycyrrhizae 185g according to the following number of weight ratio.
It is subsequent use that above-mentioned each single medicinal material is ground into 100 purpose powder, gets the powder of above-mentioned raw materials medicine according to the above ratio, and fully mix homogeneously is processed the oral Chinese patent medicine of powder type.
Claims (2)
1. the leukodermic Chinese medicine of treatment is characterized in that being made up of according to the following number of weight ratio following component: Radix Aconiti Kusnezoffii: Rhizoma Chuanxiong: Radix Angelicae Sinensis: Fructus Psoraleae: the Radix Angelicae Dahuricae: Sanguis Draxonis: Flos Carthami: Radix Aconiti: Periostracum Cicadae: the Radix Astragali: Poria: Radix Glycyrrhizae=50-80:500-750:150-200:400-600:150-200:100-130:100-140:50-80:50-75:200-300:150-200:150-300.
2. the leukodermic Chinese medicine of a kind of treatment according to claim 1 is characterized in that being made up of according to the following number of weight ratio following component: Radix Aconiti Kusnezoffii: Rhizoma Chuanxiong: Radix Angelicae Sinensis: Fructus Psoraleae: the Radix Angelicae Dahuricae: Sanguis Draxonis: Flos Carthami: Radix Aconiti: Periostracum Cicadae: the Radix Astragali: Poria: Radix Glycyrrhizae=60:620:180:500:180:120:125:60:65:260:170:220.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103268117A CN102335312B (en) | 2011-10-25 | 2011-10-25 | Chinese medicine for treating vitiligo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103268117A CN102335312B (en) | 2011-10-25 | 2011-10-25 | Chinese medicine for treating vitiligo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102335312A true CN102335312A (en) | 2012-02-01 |
| CN102335312B CN102335312B (en) | 2012-12-12 |
Family
ID=45511412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103268117A Expired - Fee Related CN102335312B (en) | 2011-10-25 | 2011-10-25 | Chinese medicine for treating vitiligo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102335312B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933336A (en) * | 2014-04-15 | 2014-07-23 | 郎溪县志瑞企业信息服务有限公司 | Traditional Chinese medicine combination for treating leucoderma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518993A (en) * | 2003-01-22 | 2004-08-11 | 雷金明 | Vifiligo pill |
-
2011
- 2011-10-25 CN CN2011103268117A patent/CN102335312B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518993A (en) * | 2003-01-22 | 2004-08-11 | 雷金明 | Vifiligo pill |
Non-Patent Citations (2)
| Title |
|---|
| 《中医研究》 20051125 卢良君等 220首治疗白癜风内服中药处方的数据统计及用药分析 28-30 1、2 第18卷, 第11期 * |
| 卢良君等: "220首治疗白癜风内服中药处方的数据统计及用药分析", 《中医研究》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933336A (en) * | 2014-04-15 | 2014-07-23 | 郎溪县志瑞企业信息服务有限公司 | Traditional Chinese medicine combination for treating leucoderma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102335312B (en) | 2012-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102698211B (en) | Chinese medicinal formulae for treating breast lobular hyperplasia and adenofibrome of breast | |
| KR20120072486A (en) | Herbal medicnes for treating diabetic neuropathy | |
| CN102198226A (en) | Chinese herbal medicine composition for treating cancer | |
| CN102335312B (en) | Chinese medicine for treating vitiligo | |
| CN102743645B (en) | Chinese medicinal preparation for treating premature ejaculation | |
| CN105079369B (en) | A kind of application of the Chinese medicine composition of replenishing kidney and strengthening bone in the drug that osteoporosis caused by arimedex is treated in preparation | |
| CN101057922B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN102552729B (en) | Medicament for treating mesangial proliferative glomerulonephritis | |
| CN101926857A (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN102716436A (en) | Capsule for treating atrophic gastritis | |
| CN101940624B (en) | Chinese medicinal lotion for treating vitiligo | |
| CN102228538A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN102743580B (en) | Traditional Chinese medicine pill for treating vitligo | |
| CN106266958A (en) | A kind of Chinese medicine formula treating interstitial pulmonary fibrosis | |
| CN102727854B (en) | Traditional Chinese medicine for treatment of gastric cancer | |
| CN101152360A (en) | Traditional Chinese medicine for treating adverse effect of mammary cancer endocrine | |
| CN101940695B (en) | Chinese medicinal ointment for treating vitiligo and preparation method thereof | |
| CN101543536A (en) | Chinese medicinal preparation for treating rhinitis | |
| CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago | |
| CN1876082A (en) | A Chinese medicine for treating femoral head necrosis and preparation method thereof | |
| CN105106706A (en) | Externally-used liniment for treating allergic dermatitis | |
| CN105213771A (en) | A kind of medicine for the treatment of apoplexy and preparation method thereof | |
| CN104000957A (en) | Pharmaceutical composition for preventing and treating liver cancer and preparing method of pharmaceutical composition for preventing and treating liver cancer | |
| CN100493560C (en) | Capsule pills for eliminating breast nodule, and preparation method | |
| CN104208588A (en) | Traditional Chinese medicine preparation for treating tumor diseases and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121212 Termination date: 20151025 |
|
| EXPY | Termination of patent right or utility model |